## Abstract Studies of amplification and/or overexpression of c‐myc, HER‐2/neu, and H‐ras in breast cancer have shown that each is associated with a poor prognosis. The purpose of this study was to explore the possibility that there is a preferred sequence of amplification of these oncogenes in bre
Focal amplification and oncogene dependency of GAB2 in breast cancer
✍ Scribed by Bocanegra, M; Bergamaschi, A; Kim, Y H; Miller, M A; Rajput, A B; Kao, J; Langerød, A; Han, W; Noh, D -Y; Jeffrey, S S
- Book ID
- 109971150
- Publisher
- Nature Publishing Group
- Year
- 2009
- Tongue
- English
- Weight
- 581 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Alterations in the gene copy numbers of the proto-oncogenes HERZ/neu and c-myc in primary human breast cancer investigated in 73 patients. We detected amplification of H€R2/ neu in 17 patient samples and amplification of c-myc in I I, while amplification of both was seen in 6 samples. There was no c
The role of int-2 oncogene amplification on the prognosis of breast cancer patients was investigated in 128 patients with node-negative primary breast cancers given first-line local-regional treatments until relapse and with a median follow-up of 65 months. Tumours had been previously characterised
Total tumor cathepsin D (TCD) levels were determined prospectively by a radioimmunometric assay in tumor c y t o d of 858 primary breast cancer patients diagnosed between 1989-1991. In 581 of these patients, tumor HER-l/neu oncogene amplification was simultaneously determined. In a "traininset" of 3